The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive, single-day educational symposium scheduled for January 24, 2026, in Jeddah, Saudi Arabia.

Organized by the European Society for Medical Oncology (ESMO), this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle East. The program focuses on the biological function of CDK4/6 in breast cancer and the practical integration of CDK4/6 inhibitors into the treatment landscape for both early-stage and metastatic hormone receptor-positive (HR+) / HER2-negative breast cancer.